Which antiplatelet agent acts as a monoclonal antibody against the Glycoprotein IIb/IIIa receptor?
Show answer and explanation
Correct answer: Abciximab (ReoPro)
Abciximab is the Fab fragment of a chimeric human-murine monoclonal antibody. It binds to the GP IIb/IIIa receptor on the platelet surface, preventing the binding of fibrinogen and von Willebrand factor.
Keep practicing
More Antiplatelet Drugs questions
- What is the mechanism of action of Dipyridamole when used as an antiplatelet agent?
- Prasugrel is contraindicated in which of the following patient populations due to an increased risk of intracranial hemorrhage?
- Vorapaxar is a newer antiplatelet drug that targets which specific receptor?
- Which side effect is uniquely associated with Ticagrelor therapy and may lead to drug discontinuation?
- What is the rationale for using 'Dual Antiplatelet Therapy' (DAPT) in patients following coronary stent placement?
- Which of the following agents is a synthetic heptapeptide that reversibly inhibits the Glycoprotein IIb/IIIa receptor?